As of 4:02pm ET
| +0.13 / +3.24%|
The 6 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 1.50. The median estimate represents a -27.54% decrease from the last price of 4.14.
The current consensus among 6 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.